TNF-a Suppresses a-Smooth Muscle Actin Expression in Human Dermal Fibroblasts: An Implication for Abnormal Wound Healing

Abnormal wound healing encompasses a wide spectrum, from chronic wounds to hypertrophic scars. Both conditions are associated with an abnormal cytokine profile in the wound bed. In this study, we sought to understand the dynamic relationships between myofibroblast differentiation and mechanical performance of the collagen matrix under tissue growth factor–b (TGF-b) and tumor necrosis factor–a (TNF-a) stimulation. We found TGF-b increased a-smooth muscle actin (a-SMA) and TNF-a alone decreased the basal a-SMA expression. When TGF-b1 and TNF-a were both added, the a-SMA expression was suppressed below the baseline. Real-time PCR showed that TNF-a suppresses TGF-b1-induced myofibroblast (fibroproliferative) phenotypic genes, for example, a-SMA, collagen type 1A, and fibronectin at the mRNA level. TNF-a suppresses TGF-b1-induced gene expression by affecting its mRNA stability. Our results further showed that TNF-a inhibits TGF-b1-induced Smad3 phosphorylation via Jun N-terminal kinase signaling. Mechanical testing showed that TNF-a decreases the stiffness and contraction of the lattices after 5 days in culture. We proposed that changes in a-SMA, collagen, and fibronectin expression result in decreased contraction and stiffness of collagen matrices. Therefore, the balance of cytokines in a wound defines the mechanical properties of the extracellular matrix and optimal wound healing.